Companies in #Graft-Versus-Host Disease
Found 1 company operating in this sector.
Commercial-stage oncology company whose approved medicines include Revuforj (revumenib) for relapsed or refractory acute leukemia and Niktimvo (axatilimab) for chronic graft-versus-host disease.